Ebiotec is a biotechnology company whose main activities are clinical genetics and genomics, the development of biotechnological products of marine and vegetal origin, and industrial lyophilization.

The goals of our company lie in the development of novel diagnostic products with applications in genomic medicine, and the molecular diagnosis of prevalent diseases. By using DNA technology we provide society and medicine with new predictive tools which help us anticipate the onset of disease and enable more accurate diagnosis.
Our scientists work to find answers in nature, and natural resources from marine and vegetal origin, which enable us to bring to the market new compounds with preventive and nutraceutical value, in order to improve human health and well-being.
One of the main concerns suffered by developed societies nowadays is the aging of its population and the emerging diseases related to aging. Thus, Ebiotec is committed to research into cardiovascular and cerebrovascular diseases as well as into nutritional issues that worsen health and lead to disease.
At
Ebiotec we work with the scientific community and with health professionals to optimize human health and well-being.
With this spirit of cooperation in mind and with the support of our board of scientists and researchers, we invite you to enter the world of
Ebiotec.
Ramón Cacabelos M.D., Ph.D., D.M.Sc.
President